NO842969L - Fremgangsmaate ved fremstilling av fenylkinolincarboxylsyrer og derivater derav - Google Patents

Fremgangsmaate ved fremstilling av fenylkinolincarboxylsyrer og derivater derav

Info

Publication number
NO842969L
NO842969L NO842969A NO842969A NO842969L NO 842969 L NO842969 L NO 842969L NO 842969 A NO842969 A NO 842969A NO 842969 A NO842969 A NO 842969A NO 842969 L NO842969 L NO 842969L
Authority
NO
Norway
Prior art keywords
phenylkinolincarboxylic
derivatives
acids
procedure
preparation
Prior art date
Application number
NO842969A
Other languages
English (en)
Other versions
NO167510C (no
NO167510B (no
Inventor
David Paul Hesson
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO842969L publication Critical patent/NO842969L/no
Publication of NO167510B publication Critical patent/NO167510B/no
Publication of NO167510C publication Critical patent/NO167510C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO842969A 1983-07-22 1984-07-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer NO167510C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631983A 1983-07-22 1983-07-22
US60510484A 1984-04-30 1984-04-30

Publications (3)

Publication Number Publication Date
NO842969L true NO842969L (no) 1985-01-23
NO167510B NO167510B (no) 1991-08-05
NO167510C NO167510C (no) 1991-11-13

Family

ID=27058797

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842969A NO167510C (no) 1983-07-22 1984-07-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer

Country Status (16)

Country Link
EP (1) EP0133244B1 (no)
AU (1) AU583793B2 (no)
CA (1) CA1288436C (no)
DE (1) DE3483704D1 (no)
DK (1) DK358784A (no)
ES (1) ES534509A0 (no)
FI (1) FI86987C (no)
GR (1) GR82234B (no)
HK (1) HK142395A (no)
HU (1) HU194832B (no)
IE (1) IE57627B1 (no)
IL (1) IL72471A (no)
NO (1) NO167510C (no)
NZ (1) NZ208966A (no)
PT (1) PT78960B (no)
SU (2) SU1393314A3 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
BR8807870A (pt) * 1987-12-28 1990-11-13 Dowelanco Propionatos de fenoxifenoxi, intermediarios dos mesmos e metodos de preparacao
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US4968702A (en) * 1989-01-17 1990-11-06 American Cyanamid Company Substituted quinolinecarboxylic acids
US4918077A (en) * 1989-01-25 1990-04-17 E. I. Du Pont De Nemours & Co., Inc. 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents
DE3905339A1 (de) * 1989-02-22 1990-09-06 Basf Ag Chinolin-4-carbonsaeurederivate und deren verwendung
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
AP1444A (en) * 1997-05-28 2005-07-18 Aventis Pharma Inc Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases.
DE69814012T2 (de) * 1997-12-19 2004-04-01 Eli Lilly And Co., Indianapolis Hypoglykàmische imidazoline derivate
US20060111368A1 (en) * 2002-06-26 2006-05-25 Kyowa Hakko Kogyo Co., Ltd. Phosphodiesterase inhibitor
US8232310B2 (en) 2006-12-29 2012-07-31 Georgetown University Targeting of EWS-FLI1 as anti-tumor therapy
KR102145835B1 (ko) 2012-04-12 2020-08-20 조지타운 유니버시티 유잉육종계 종양을 치료하기 위한 조성물
US9511050B2 (en) 2013-10-24 2016-12-06 Georgetown University Methods and compositions for treating cancer
AU2014352920A1 (en) 2013-11-22 2016-06-23 Genzyme Corporation Novel methods for treating neurodegenerative diseases
EP3204376B1 (en) 2014-10-09 2023-04-19 Oncternal Therapeutics, Inc. Indolinone compounds and uses thereof
KR102375929B1 (ko) 2016-03-31 2022-03-16 온크터널 테라퓨틱스, 인코포레이티드. 인돌린 유사체 및 이의 용도
MX2019000867A (es) 2016-07-29 2019-09-16 Oncternal Therapeutics Inc Usos de compuestos de indolinona.
KR20220132538A (ko) * 2019-12-26 2022-09-30 오하이오 스테이트 이노베이션 파운데이션 디하이드로오로테이트 데하이드로게나제를 억제하는 방법 및 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE502610A (no) * 1950-04-18
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds

Also Published As

Publication number Publication date
FI86987B (fi) 1992-07-31
SU1393314A3 (ru) 1988-04-30
GR82234B (no) 1984-12-13
NO167510C (no) 1991-11-13
IL72471A0 (en) 1984-11-30
HU194832B (en) 1988-03-28
ES8507498A1 (es) 1985-09-01
NZ208966A (en) 1986-12-05
SU1452480A3 (ru) 1989-01-15
IE841873L (en) 1985-01-22
DE3483704D1 (de) 1991-01-17
PT78960A (en) 1984-08-01
EP0133244A3 (en) 1985-12-11
EP0133244A2 (en) 1985-02-20
NO167510B (no) 1991-08-05
CA1288436C (en) 1991-09-03
PT78960B (en) 1986-10-20
AU583793B2 (en) 1989-05-11
DK358784D0 (da) 1984-07-20
FI86987C (fi) 1992-11-10
HUT35248A (en) 1985-06-28
FI842928A0 (fi) 1984-07-20
FI842928A (fi) 1985-01-23
HK142395A (en) 1995-09-15
IL72471A (en) 1988-11-15
AU3085284A (en) 1985-01-24
EP0133244B1 (en) 1990-12-05
DK358784A (da) 1985-01-23
ES534509A0 (es) 1985-09-01
IE57627B1 (en) 1993-02-10

Similar Documents

Publication Publication Date Title
NO843956L (no) Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
NO157500C (no) Fremgangsmaate for fremstilling av eddiksyreanhydrid og eddiksyre.
RO90861A (ro) Procedeu pentru prepararea etielnglicolului
NO844710L (no) Fremgangsmaate for fremstilling av hoeyrent protein
NO169591C (no) Fremgangsmaate for fremstilling av n-alkylerte dipeptider og deres estere
NO173498C (no) Analogifremgangsmaate for fremstilling av substituerte 9-amino-tetrahydroakridiner
NO842969L (no) Fremgangsmaate ved fremstilling av fenylkinolincarboxylsyrer og derivater derav
NO176922C (no) Fremgangsmåte for fremstilling av bifunksjonelle proteiner
NO150879C (no) Fremgangsmaate for fremstilling av d-camforat av l-carnitinamid og d-camforat av d-carnitinamid
NO844631L (no) Fremgangsmaate for fremstilling av tremasse
NO170019C (no) Fremgangsmaate for fremstilling av deglucoteicoplanin (antibiotikum l 17392)
NO845207L (no) Fremgangsmaate for fremstilling av diaminopolyalkenyletere
NO834461L (no) Fremgangsmaate ved fremstilling av l-carnitin og utgangsmaterialer anvendt ved fremgangsmaaten
NO844978L (no) Fremgangsmaate ved fremstilling av nye aminoguanidinderivater
NO832830L (no) Fremgangsmaate for fremstilling av alfa-arylalkansyrer
NO169126C (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin
NO820281L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
NO851758L (no) Fremgangsmaate ved fremstilling av isokinolinderivater
NO880294L (no) Fremgangsmaate for fremstilling av tetrahydrofuranderivater
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO845148L (no) Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituert-fenoksy-prostatrinsyre-derivater
NO851638L (no) Fremgangsmaate ved fremstilling av iminothiazolidin-derivater
NO169441C (no) Fremgangsmaate til fremstilling av 7-oksomitosanderivater
NO159764C (no) Fremgangsmaate og anordning ved fremstilling av pariserpoteter.
NO873069D0 (no) Fremgangsmaate for fremstilling av hydroksimsyrer av 7-oksabicykloheptan-substituerte etere og tioetere.